[PDF] Top 20 Pediatric multiple sclerosis: a review

... It is especially challenging to determine whether a child with an initial demyelinating event (IDE) will de- velop subsequent events that are consistent with MS or not. A list of “red flags” in the differential diagnosis ... See full document

... Purpose: Pediatric-onset multiple sclerosis (POMS) accounts for ~5% of all multiple sclerosis cases, and has a prevalence of ~10,000 children in the ...scoping review of the ... See full document

... in size from 14 to 95 cases, generally describe a low proportion of patients who have MS (0% – 14%), although the mean follow-up of these studies ranges from 0.5 to 8 years. The largest cohort (French and UK ... See full document

... This study represents one of the largest population-based studies of POMS to date. Even so, MS progression occurs over decades, resulting in a high rate of right-censoring in the analysis of time to EDSS 6. As with all ... See full document

... Multiple Sclerosis is a chronic degenerative disease of the central nervous system that involves functionality of the brain and spinal cord, with physical, sensory, cogni- tive and emotional responses ... See full document

... of multiple sclerosis is important not only to exclude other disorders and give prognosis but also for epidemiological studies and entering patients in multicentre clinical trials for ... See full document

... A pediatric MS sample from Canada found that patients were less likely to report European ancestry and more likely to report Asian, Middle Eastern, or Caribbean ancestry relative to the adult-onset MS Canadian ... See full document

... Results: Multiple sclerosis was diagnosed in 186 patients, 47 (25.27%) patients had disease onset before the age of 12 years; “early-onset pediatric multiple sclerosis (EOPMS)”. The ... See full document

... Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report. Multiple sclerosis[r] ... See full document

... callosal fibers, projection fibers, and association fiber pathways in pediatric patients with MS in our separate and unique cohort. We did not find significant involvement of these structures in the MCIS and ... See full document

... systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy ... See full document

... Multiple Sclerosis (MS) is a chronic immune mediated disease of the central nervous system (CNS) which is characterised by the presence of widespread lesions affecting the brain, spinal cord and optic ... See full document

... In the special article “Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis,” Rae-Grant et al. reported the findings of the Guideline Development, ... See full document

... onset pediatric MS (EOPMS) and later onset pediatric MS (LOPMS) ...for multiple comparisons (false discovery rate [FDR] criterion; α FDR = ... See full document

... of Pediatric MS Centers. Institutional review board approval was obtained at all participating sites and written informed consent was obtained from parents and assent from adolescent ...3 pediatric ... See full document

... the Pediatric MS Center at Stony Brook, NY and met 2010 McDonald [14] and/or International Pediatric MS Study Group (IPMSSG) consensus criteria for MS ...19 pediatric MS patients, 25 adult MS ... See full document

... Multiple sclerosis (MS) is a disease in which the fatty myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and scarring as well as a broad spectrum of signs ... See full document

... Support for a combined pathogenic role of HHV-6A and EBV in MS might come from studies involving disease- modifying therapies. In fact, the first trial in MS with specific anti-herpes virus treatment showed that acyclo- ... See full document

... hierarchical multiple regression analysis used to evaluate the relative contribution of several clinical variables in pre- dicting cognitive outcome (EDSS, number of relapse, MS duration, age at onset) showed that ... See full document

... younger children there was a reduced production of BO in the liquor with a higher percentage of neutrophils than older children (> 11 years) and adults, an index of prevalent and massive innate immune response to the ... See full document